SCHEMBL9682799

SCHEMBL9682799

O=C(O)C1=Cc2c(Cl)cccc21

nearest known ligand 0.44

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.44
ALDH1A1 P00352 5/20 0.43
KMT2A Q03164 3/20 0.43
MEN1 O00255 2/20 0.43
NPSR1 Q6W5P4 1/20 0.43
AKR1B1 P15121 1/20 0.39
ALPL P05186 1/20 0.37
KMO O15229 2/20 0.36
MAPK1 P28482 1/20 0.36
MCL1 Q07820 1/20 0.36
KDM4E B2RXH2 1/20 0.36
HSD17B10 Q99714 1/20 0.36
RXFP1 Q9HBX9 1/20 0.36
CYP2A6 P11509 1/20 0.35
TP53 P04637 1/20 0.35
FEN1 P39748 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9683956 0.76 ALB (0.42) KMT2AHSD17B10
SCHEMBL23908712 0.72 ALDH1A1 (0.58) TSHRALDH1A1KMT2AMEN1NPSR1
SCHEMBL10671377 0.70 ALDH1A1 (0.37) ALDH1A1KMT2AKDM4E
SCHEMBL80183 0.66 ALDH1A1 (0.64) TSHRALDH1A1KMT2AMEN1AKR1B1
Bicarbonate SCHEMBL4865957 0.66 CYP2A6 (0.59) TSHRALDH1A1KMT2AMEN1NPSR1
Bicarbonate SCHEMBL11009844 0.66 CYP2A6 (0.59) TSHRALDH1A1KMT2AMEN1NPSR1
SCHEMBL31589562 0.66 HSD17B10 (0.58) TSHRALDH1A1KMT2AMEN1MAPK1
SCHEMBL9256434 0.66 CYP2A6 (0.36) TSHRALDH1A1KMT2AMEN1KDM4E
SCHEMBL503745 0.66 MAOA (0.50) TSHRALDH1A1KMT2AMEN1NPSR1
SCHEMBL30895284 0.66 MAOA (0.50) TSHRALDH1A1KMT2AMEN1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5134147-A Antipsychotic agents ADIR ET COMPAGNIE (FR) 1992-07-28 US disclosed
US-5100902-A Dopamine and Serotonin Antagonists, Antipsychotic Agents ADIR ET COMPAGNIE (FR) 1992-03-31 US disclosed